Approval · Notice of Compliance 22013 · 2019
GALAFOLD: Notice of Compliance 22013
Issued March 28, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22013
- Date
- March 28, 2019
- Company
- Amicus Therapeutics Uk Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GALAFOLD | Not yet assigned | — |
Medicinal ingredients
- MIGALASTAT HYDROCHLORIDE 123 MG per CAP